Open App
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Divis Laboratories

Divis Laboratories

BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 27, 16:01
3678.00
8.65 (0.24%)
VOLUME 15,389
LIVE
NSE
Sep 27, 16:01
3680.20
10.2 (0.28%)
VOLUME 402,344
News on Divis Laboratories
Select Year: 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Top 10 trading ideas by experts for next 3-4 weeks as bears retain the reins

7.51 am | 26 Sep 2022 |  Source: Moneycontrol.com

Given the subdued environment, the index may touch its August lows of around 17,150 and if that gets broken, then falling below psychological 17,000 m...

Buy Divis Laboratories; target of Rs 4450: Sharekhan

11.37 am | 27 Aug 2022 |  Source: Moneycontrol.com

Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 4450 in its research report dated August ...

Buy Divis Laboratories; target of Rs 4450: Sharekhan

11.37 am | 27 Aug 2022 |  Source: Moneycontrol.com

Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 4450 in its research report dated August ...

Accumulate Divi's Laboratories; target of Rs 4140: Prabhudas Lilladher

5.39 pm | 17 Aug 2022 |  Source: Moneycontrol.com

Prabhudas Lilladher recommended accumulate rating on Divi's Laboratories with a target price of Rs 4140 in its research report dated August 15, 20...

Buy Divis Laboratories; target of Rs 4450: Sharekhan

1.42 pm | 16 Aug 2022 |  Source: Moneycontrol.com

Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 4450 in its research report dated August ...

Divi’s Labs: Focus on green chemistry

11.08 am | 16 Aug 2022 |  Source: Moneycontrol.com

The drug firm is set to benefit from investments in productivity and new product range...

Buy Divi’s Laboratories; target of Rs 4340: Motilal Oswal

5.52 pm | 15 Aug 2022 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Divi’s Laboratories recommended buy rating on the stock with a target price of Rs 4340 in its research report dated Augu...

Buy Divi's Laboratories; target of Rs 4315: ICICI Direct

11.13 am | 14 Aug 2022 |  Source: Moneycontrol.com

ICICI Direct is bullish on Divi's Laboratories has recommended buy rating on the stock with a target price of Rs 4315 in its research report dated...

Divi's Labs Q1 Result | Profit jumps 26% to Rs 702 crore led by other income, lower tax cost

2.54 pm | 12 Aug 2022 |  Source: Moneycontrol.com

Consolidated revenue from operations in Q1FY23 grew by 15 percent to Rs 2,254.5 crore compared to corresponding period last fiscal....

Divi's Q1 Poll| Solid profit, revenue growth on cards, but costs could dent margin

10.43 am | 12 Aug 2022 |  Source: Moneycontrol.com

Shares of Divi's have been under pressure this fiscal, as margin are weighed down by input cost, China lockdowns, and a spike in freight rates....

Divi's Q1 Poll| Solid profit, revenue growth on cards, but costs could dent margin

10.43 am | 12 Aug 2022 |  Source: Moneycontrol.com

Shares of Divi's have been under pressure this fiscal, as margin are weighed down by input cost, China lockdowns, and a spike in freight rates....

Divi’s Labs: Steady margin profile amid cost headwind

11.14 am | 25 May 2022 |  Source: Moneycontrol.com

Earnings trigger for the medium term is Contrast Media API opportunity, where there is limited competition...

Divis Labs Standalone March 2022 Net Sales at Rs 2,495.03 crore, up 45.2% Y-o-Y

11.33 am | 24 May 2022 |  Source: Moneycontrol.com

NULL...

Divis Labs Consolidated March 2022 Net Sales at Rs 2,518.44 crore, up 40.84% Y-o-Y

11.08 am | 24 May 2022 |  Source: Moneycontrol.com

NULL...

1 2
Quick Links for Divis Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.